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Australia was considered free of rabies and
the rabieslike viruses of the genus Lyssavirus
until the recognition in 1996 of Australian bat
lyssavirus (ABL) as the cause of a rabieslike
disease in a black flying fox (Pteropus alecto)(1)
and a wildlife caretaker (2). While serotypic,
antigenic, and sequence analysis show that ABL
is closely related to classic rabies virus and
European bat lyssavirus (1), phylogenetic
analysis has clearly demonstrated that ABL
represents a new genotype, genotype 7 (3).
Australia is still considered free of terrestrial
(genotype 1) classic rabies (4). Rabies vaccine
and antirabies immunoglobulin protect labora-
tory animals against ABL infection (5), and their
use pre- and post-ABL exposure is recommended
for humans (6,7).
On the morning of December 8, 1997, two
juvenile black flying foxes were found clinging to
each other and vocalizing in a residential area
near an urban flying fox colony. An experienced,
rabies-vaccinated wildlife caretaker retrieved
the two animals from an unusually low tree
roost. On the basis of body weight and forearm
measurements, their age was estimated at 2 to 3
weeks, an age of total maternal dependency.
Their physical condition was normal.
Both animals, Bat 1 (male) and Bat 2
(female), remained with the original caretaker
for 2 days before being placed with two different
caretakers for hand-rearing. Bat 1 was
communally housed with another orphaned
black flying fox, and Bat 2 was housed with two
others. For the next 5 weeks, all the bats were
clinically normal. However, in week 6, Bat 1
began to exhibit signs of neurologic disease. The
caretaker first observed the bats sudden and
progressive aggression toward its companion
and separated them. Throughout day 1 of illness,
the bat periodically frothed at the mouth and
had repeated lordotic spasms, during which it
vocalized loudly. Treatment with oral amoxycillin
was initiated. On day 2, the bat was calmer but
still vocal, attempting to bite objects and eating
little. On day 3, it was no longer aggressive and
was only able to eat pulped food and milk. On day
4, it was seen by a veterinarian, who noted severe
pharyngitis, and administered injectable dexam-
ethasone. The bat was much more alert that
evening and ate solid food well. The dexametha-
sone injection was repeated on day 5; the bat
remained alert and ate solid food overnight. On
day 6, it was dysphagic and was again offered
pulped foods and liquids. On days 7 and 8, it was
unable to roost normally, lay supine, was
progressively dysphagic, had diarrhea, and was
losing weight. On day 9, it rapidly got worse and
died. The carcass was submitted to the
Queensland Department of Primary Industries
Animal Research Institute for necropsy.
The emaciated carcass had poor pectoral
muscle development and no perirenal, pericar-
dial, or mesenteric fat reserves. ABL infection
was diagnosed by fluorescein-labeled antirabies
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monoclonal globulin (CENTOCOR) in a fluores-
cence antibody test (FAT) on impression smears
of fresh brain. With the absence of other
lyssaviruses in Australia (1), a positive reaction
with this lyssavirus genus-specific antibody is
considered diagnostic for ABL. Sections of brain
showed nonspecific, nonsuppurative meningoen-
cephalitis with perivascular cuffs of mono-
nuclear cells and widespread focal gliosis.
Numerous neurons contained eosinophilic inclu-
sion bodies, which are highly suggestive of
lyssavirus infection.
Immunoperoxidase staining of formalin-
fixed, paraffin-embedded sections of brain with a
monoclonal antinucleoprotein antibody (Clone
HAM, provided by R. Zanoni, Berne University,
Switzerland) detected lyssavirus antigen in
neurons of the frontal cortex, hippocampus,
brain stem, and cerebellum, including Purkinje
cells. This antigen distribution is consistent with
previous reports of rabies (8). The diagnosis was
independently confirmed at the Commonwealth
Scientific and Industrial Research Organisations
Australian Animal Health Laboratory by FAT,
immunoperoxidase staining, virus isolation in
murine neuroblastoma cells, and sequence
analysis of polymerase chain reaction (PCR)
product (P. Daniels, pers. comm.). No blood was
available for serologic testing.
After ABL infection was diagnosed in Bat 1,
the Brisbane Southside Public Health Unit
received information that up to eight persons
had been bitten or scratched by the bat in the
weeks before and during its illness. Six were bat
handlers who had received postexposure
treatment with five doses of rabies human
diploid cell vaccine (HDCV) during a 1996
campaign that followed the diagnosis of the first
human case of ABL (2,7). Two were unvaccinated
members of the principal bat caretakers
household. Despite recommendations that un-
vaccinated members of bat caretakers house-
holds not handle bats, the two had come into
regular contact with the bat and may have been
scratched during that time.
Lyssavirus prophylaxis was commenced in
accordance with Australian recommendations
(6,7). All eight persons provided blood for rabies
serologic testing (indirect-enzyme linked
immunosorbent assay [ELISA]). The six vacci-
nated bat handlers had titers of 1.130 IU/ml to
>8.80 IU/ml 12 months after their initial
vaccinations (World Health Organization
recommended protective level for rabies = 0.5 IU/
ml [9]). Each of these received two further
intramuscular doses of 1.0 ml of HDCV,
according to the Australian recommendations
for postexposure treatment of vaccinated
persons. The two unvaccinated persons had
titers of <0.13 IU/ml (nonimmune) and received
the standard postexposure treatment for
unvaccinated persons: 20 IU per kg of human
rabies immune globulin (HRIG) by intramuscu-
lar injection and five intramuscular doses of 1.0
ml of HDCV. All eight remain well 10 months
after the incident.
Throughout this episode, Bat 2 and the other
three bats that had been directly or indirectly in
contact with the infected bat remained healthy.
After the diagnosis of ABL in Bat 1, these four
animals were quarantined for observation at the
Animal Research Institute for 11 weeks and then
euthanized. All were antibody-nega-
tive (<0.5 IU/ml) by rabies rapid fluorescent
focus inhibition test when quarantined and
remained so during the observation period.
Brain impression smears from the four were
negative for lyssavirus antigen by FAT.
This case of naturally occurring ABL
infection is of particular interest for several
reasons. First, the astute observations of the bat
caretaker provide possibly the first record of the
clinical course of natural ABL infection in a
flying fox. Second, to our knowledge, this is the
first recorded case of ABL disease in a maternally
dependent juvenile. Third, the case history
provides the first indication of the incubation
period and length of clinical disease in naturally
infected flying foxes. Natural in utero infection
with lyssaviruses is not known to occur (10), and
the four flying foxes in contact with Bat 1 were
unlikely to be the source of infection as they
subsequently tested negative for ABL antibody
and antigen. The infection appears to have
occurred in the 2 to 3 weeks before the rescue
and, after an incubation period of 6 to 9 weeks,
produced 9 days of clinical disease. Infection in
Bat 1 most probably resulted from a bite from an
ABL-infected bat. This bat may have been Bat 1s
dam.
This episode demonstrates the necessity of
examining for ABL any flying fox that has
bitten or scratched a person and of improving
community and professional awareness of the
disease and associated risks. Costly
postexposure treatment with HRIG can be
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avoided if only vaccinated persons handle
Australian bats.
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